“Transporting vital healthcare deliveries requires more than just standard logistics. It depends upon an intelligent, highly specialized network built for patient-critical needs,” says Brie Carere, executive vice president and chief customer officer, FedEx. “Every shipment we move in this space has the potential to support a researcher, a medical professional, or most importantly, a patient waiting for care. To meet these critical demands, FedEx Life Sciences brings together our global network, advanced monitoring, and specialized expertise to make supply chains smarter and more resilient.”

Nick Gennari, president of healthcare and life sciences

As part of the launch, Nick Gennari will exclusively focus on this segment as president of healthcare and life sciences. Gennari joined FedEx in 1992 and has spent much of his more than 30-year tenure driving strategic sales and supply chain solutions for global healthcare, aerospace, and high-tech customers, before assuming leadership of the healthcare vertical in 2024. His appointment to lead this newly specialized organization reflects the FedEx commitment to pairing deep, long-standing sector expertise with its global logistics and technological capabilities. Gennari and his team’s efforts have been instrumental in growing FedEx healthcare revenue to approximately USD 10 billion globally, the company states.

“Healthcare supply chains are becoming more complex, and the stakes are deeply personal,” says Nick Gennari, president of healthcare and life sciences, FedEx. “FedEx Life Sciences gives our customers a more focused team, stronger coordination, and specialized expertise to help them move critical healthcare shipments with confidence. Our role is to provide the certainty, visibility, and global reach healthcare innovators need when every shipment matters.”

Significant investments

FedEx Life Sciences builds on significant investments the company has made in healthcare infrastructure and technology. In 2025, FedEx secured IATA CEIV Pharma Corporate Certification, achieving corporate-level certification for ground handling across its air hubs and ramps. In addition, FedEx recently appointed a vice president of global quality, healthcare, and life sciences to oversee global quality management systems for the organization and support the standards required by pharmaceutical and medical device manufacturers.

FedEx has also expanded its life sciences footprint with a total of six Life Sciences Centers globally. Additionally, a direct flight between Indianapolis and Dublin has strengthened transatlantic connectivity between these two critical pharmaceutical manufacturing hubs, as the company continues to connect global pharmaceutical epicenters.